The Latest

Avanos Medical, Inc. to Present at the Virtual Raymond James 42nd Annual Institutional Investors Conference

byAtlanta Tech News
February 25, 2021
1 minute read
Total
0
Shares
0
0
0
0
0

Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president and chief financial officer, will present at the Virtual Raymond James 42nd Annual Institutional Investors Conference Mon., March 1 at approximately 3:50 p.m., ET

A live webcast of conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.

About Avanos Medical:

Avanos Medical (NYSE: AVNS) is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients’ quality of life. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today’s most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries. For more information, visit www.avanos.com and follow Avanos Medical on Twitter (@AvanosMedical), LinkedIn and Facebook.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Share 0
Leave a Reply
Related Posts
Read More

LexisNexis Risk Solutions Develops Proprietary System to Interpret Vehicle Safety Features for Insurance Industry

LexisNexis® Risk Solutions, the leading data, analytics and technology provider for the insurance industry, has created the first purpose-driven Advanced Driver Assistance Systems (ADAS) and vehicle safety classification system for auto insurance pricing and claims analysis. The new classification system helps insurers break down barriers through access to relevant data and insights from automakers' ADAS features. It will be leveraged in the soon-to-be released LexisNexis® Vehicle Build, a solution that identifies and categorizes specific ADAS equipped features at the VIN-level, enabling insurers to establish the differences in risk profile associated with these features.

byAtlanta Tech News